U0126-EtOH: A Selective MEK1/2 Inhibitor for Advanced Biological Research and Drug Discovery

Explore the potent capabilities of U0126-EtOH, a key MEK1/2 inhibitor driving innovation in life sciences.

Get a Quote & Sample

Advantages Offered by the Product

High Selectivity and Potency

U0126-EtOH exhibits superior selectivity for MEK1/2, providing accurate research outcomes by minimizing off-target effects. This potency is crucial for studying the MAPK pathway with precision.

Versatile Research Applications

From investigating inflammatory responses to understanding antiviral mechanisms, U0126-EtOH supports a broad spectrum of biological research, aiding in the discovery of new therapeutic targets.

Reliable In Vitro and In Vivo Efficacy

The compound's proven efficacy in both laboratory and animal studies underscores its reliability as a research reagent, supporting the entire spectrum of scientific inquiry.

Key Applications

MAPK Pathway Research

U0126-EtOH is instrumental in dissecting the intricate details of the MAPK signaling cascade, offering critical insights for various cellular processes.

Inflammation Studies

Its role in modulating inflammatory responses makes U0126-EtOH a key compound for researchers investigating pathogenesis and therapeutic interventions for inflammatory diseases.

Antiviral Research

The demonstrated antiviral activity of U0126-EtOH opens avenues for exploring its potential in developing novel treatments against viral infections.

T-Cell Proliferation Studies

By inhibiting T-cell proliferation, U0126-EtOH provides a valuable model for studying immune system regulation and developing immunotherapies.